Convenio de Suministro de Medicamento Hbsjo 2013
ADQUISICION DE MEDICAMENTOS POR MEDIO DE CONVENIO DE SUMINISTRO DE MEDICAMENTOS INSULINAS Y REFRIGERADOS PARA EL HOSPITAL BASE SAN JOSE OSORNOPOR UN PERIODO DE 12 MESES
18 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1545-2056-SE15 | 10-03-2015 | Laboratorio Chile S.A. | $1.166.200 |
| 1545-1391-SE15 | 17-02-2015 | Novo Nordisk Farmaceutica Limitada | $386.512 |
| 1545-1393-SE15 | 17-02-2015 | Aventis Pharma Holding Gmbh | $1.980.077 |
| 1545-1392-SE15 | 17-02-2015 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $309.400 |
| 1545-407-SE15 | 13-01-2015 | Laboratorio Chile S.A. | $1.166.200 |
| 1545-405-SE15 | 13-01-2015 | Aventis Pharma Holding Gmbh | $1.558.091 |
| 1545-10804-SE14 | 05-12-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $618.800 |
| 1545-10802-SE14 | 05-12-2014 | Novo Nordisk Farmaceutica Limitada | $331.296 |
| 1545-10801-SE14 | 05-12-2014 | Aventis Pharma Holding Gmbh | $2.109.930 |
| 1545-9792-SE14 | 06-11-2014 | Novo Nordisk Farmaceutica Limitada | $1.104.320 |
| 1545-9797-SE14 | 06-11-2014 | Novartis Chile S.A. | $508.001 |
| 1545-9796-SE14 | 06-11-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $618.800 |
| 1545-9793-SE14 | 06-11-2014 | Aventis Pharma Holding Gmbh | $4.219.859 |
| 1545-9622-SE14 | 03-11-2014 | Laboratorio Chile S.A. | $446.250 |
| 1545-9539-SE14 | 29-10-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $928.200 |
| 1545-9129-SE14 | 15-10-2014 | Novartis Chile S.A. | $254.001 |
| 1545-9035-SE14 | 09-10-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $495.040 |
| 1545-9036-SE14 | 09-10-2014 | Novo Nordisk Farmaceutica Limitada | $828.240 |
| 1545-9025-SE14 | 09-10-2014 | Aventis Pharma Holding Gmbh | $1.882.699 |
| 1545-8715-SE14 | 30-09-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $371.280 |
| 1545-8673-SE14 | 29-09-2014 | Aventis Pharma Holding Gmbh | $97.378 |
| 1545-8473-SE14 | 17-09-2014 | Aventis Pharma Holding Gmbh | $97.378 |
| 1545-8218-SE14 | 08-09-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $495.040 |
| 1545-8116-SE14 | 06-09-2014 | Aventis Pharma Holding Gmbh | $1.460.713 |
| 1545-7989-SE14 | 01-09-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $309.400 |
| 1545-7519-SE14 | 14-08-2014 | Novo Nordisk Farmaceutica Limitada | $828.240 |
| 1545-7523-SE14 | 14-08-2014 | Aventis Pharma Holding Gmbh | $2.531.915 |
| 1545-7372-SE14 | 12-08-2014 | Laboratorio Chile S.A. | $583.100 |
| 1545-7371-SE14 | 12-08-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $618.800 |
| 1545-6119-SE14 | 04-07-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $495.040 |
| 1545-6124-SE14 | 04-07-2014 | Novo Nordisk Farmaceutica Limitada | $828.240 |
| 1545-6123-SE14 | 04-07-2014 | Aventis Pharma Holding Gmbh | $3.444.907 |
| 1545-6120-SE14 | 04-07-2014 | Laboratorio Chile S.A. | $583.100 |
| 1545-5528-SE14 | 18-06-2014 | Laboratorio Silesia S.A. | $456.960 |
| 1545-5172-SE14 | 07-06-2014 | Novartis Chile S.A. | $762.002 |
| 1545-5186-SE14 | 07-06-2014 | Laboratorio Chile S.A. | $583.100 |
| 1545-5187-SE14 | 07-06-2014 | Aventis Pharma Holding Gmbh | $4.588.640 |
| 1545-5169-SE14 | 07-06-2014 | Novo Nordisk Farmaceutica Limitada | $828.240 |
| 1545-5171-SE14 | 07-06-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $618.800 |
| 1545-4463-SE14 | 16-05-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $618.800 |
| 1545-4208-SE14 | 05-05-2014 | Laboratorio Silesia S.A. | $342.720 |
| 1545-4204-SE14 | 05-05-2014 | Aventis Pharma Holding Gmbh | $1.082.900 |
| 1545-4207-SE14 | 05-05-2014 | Novartis Chile S.A. | $762.002 |
| 1545-4205-SE14 | 05-05-2014 | Novo Nordisk Farmaceutica Limitada | $662.592 |
| 1545-4206-SE14 | 05-05-2014 | Aventis Pharma Holding Gmbh | $486.889 |
| 1545-3416-SE14 | 11-04-2014 | Aventis Pharma Holding Gmbh | $973.825 |
| 1545-3334-SE14 | 10-04-2014 | Laboratorio Silesia S.A. | $228.480 |
| 1545-3223-SE14 | 07-04-2014 | Novartis Chile S.A. | $762.002 |
| 1545-3220-SE14 | 07-04-2014 | Novo Nordisk Farmaceutica Limitada | $276.080 |
| 1545-3221-SE14 | 07-04-2014 | Aventis Pharma Holding Gmbh | $584.266 |
| 1545-3224-SE14 | 07-04-2014 | Laboratorio Chile S.A. | $874.650 |
| 1545-3225-SE14 | 07-04-2014 | Laboratorio Silesia S.A. | $28.560 |
| 1545-3038-SE14 | 03-04-2014 | Aventis Pharma Holding Gmbh | $773.500 |
| 1545-2208-SE14 | 06-03-2014 | Aventis Pharma Holding Gmbh | $486.889 |
| 1545-2209-SE14 | 06-03-2014 | Laboratorio Chile S.A. | $1.166.200 |
| 1545-2210-SE14 | 06-03-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $371.280 |
| 1545-2211-SE14 | 06-03-2014 | Novartis Chile S.A. | $508.001 |
| 1545-2207-SE14 | 06-03-2014 | Novo Nordisk Farmaceutica Limitada | $1.104.320 |
| 1545-1849-SE14 | 27-02-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $123.760 |
| 1545-1082-SE14 | 03-02-2014 | Laboratorio Chile S.A. | $1.166.200 |
| 1545-1084-SE14 | 03-02-2014 | Pfizer Chile S.A. | $2.955.960 |
| 1545-1083-SE14 | 03-02-2014 | Novo Nordisk Farmaceutica Limitada | $552.160 |
| 1545-1080-SE14 | 03-02-2014 | Alpes Selection Productos Farmaceuticos Ltda. | $3.927.000 |
| 1545-1081-SE14 | 03-02-2014 | Aventis Pharma Holding Gmbh | $292.133 |
| 1545-570-SE14 | 17-01-2014 | Laboratorio Chile S.A. | $446.250 |
| 1545-569-SE14 | 17-01-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $309.400 |
| 1545-338-SE14 | 14-01-2014 | Laboratorio Chile S.A. | $583.100 |
| 1545-8396-SE13 | 14-01-2014 | Novo Nordisk Farmaceutica Limitada | $828.240 |
| 1545-8398-SE13 | 06-01-2014 | Pfizer Chile S.A. | $2.758.896 |
| 1545-8400-SE13 | 06-01-2014 | Novartis Chile S.A. | $330.201 |
| 1545-8405-SE13 | 06-01-2014 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | $123.760 |
| 1545-8397-SE13 | 30-12-2013 | Alpes Selection Productos Farmaceuticos Ltda. | $2.945.250 |
Fuente original:ficha mercadopublico.cl
